Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.
Cell therapies based on focal delivery of the inhibitory neuromodulator adenosine were previously shown to provide potent seizure suppression in animal models of epilepsy. However, hitherto used therapeutic cells were derived from rodents and thus not suitable for clinical applications. Autologous patient-derived adenosine-releasing cell implants would constitute a major therapeutic advance to avoid both xenotransplantation and immunosuppression. Here we describe a novel approach based on lentiviral RNAi mediated downregulation of adenosine kinase (ADK), the major adenosine-removing enzyme, in human mesenchymal stem cells (hMSCs), which would be compatible with autologous cell grafting in patients. Following lentiviral transduction of hMSCs with anti-ADK miRNA expression cassettes we demonstrate up to 80% downregulation of ADK and a concentration of 8.5 ng adenosine per ml of medium after incubating 10(5) cells for 8 h. hMSCs with a knockdown of ADK or cells expressing a scrambled control sequence were transplanted into hippocampi of mice 1 week prior to the intraamygdaloid injection of kainic acid (KA). While mice with control implants expressing a scrambled miRNA sequence or sham treated control animals were characterized by KA-induced status epilepticus and subsequent CA3 neuronal cell loss, animals with therapeutic ADK knockdown implants displayed a 35% reduction in seizure duration and 65% reduction in CA3 neuronal cell loss, when analyzed 24 h after KA-injection. We conclude that lentiviral expression of anti-ADK miRNA constitutes a versatile tool to generate therapeutically effective adenosine releasing hMSCs, thus representing a model system to generate patient identical autologous adult stem cell grafts.
Ren
Gaoying
G
Robert S. Dow Neurobiology Laboratories, Legacy Research, 1225 NE 2nd Avenue, Portland, OR 97232, USA.
Li
Tianfu
T
Lan
Jiang Quan
JQ
Wilz
Andrew
A
Simon
Roger P
RP
Boison
Detlev
D
D000241:Adenosine / Q000378:metabolism; D000248:Adenosine Kinase / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D015536:Down-Regulation; D018690:Excitatory Amino Acid Agonists; D005822:Genetic Vectors; D006624:Hippocampus / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D007608:Kainic Acid; D016086:Lentivirus / Q000235:genetics*; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000201:enzymology* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D034622:RNA Interference; D013226:Status Epilepticus / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D014161:Transduction, Genetic
D018690:Excitatory Amino Acid Agonists; D000248:Adenosine Kinase; D000241:Adenosine; D007608:Kainic Acid
Lancet. 2005 Aug 13-19;366(9485):592-602
16099296
J Neurosci. 2005 Sep 14;25(37):8391-401
16162921
Brain. 2005 Oct;128(Pt 10):2383-95
15930047
Brain. 2006 Jan;129(Pt 1):18-35
16317026
Neurobiol Dis. 2006 Feb;21(2):276-90
16099669
Expert Rev Neurother. 2006 Mar;6(3):397-406
16533143
Exp Neurol. 2006 Sep;201(1):32-48
16678161
Eur J Neurosci. 2003 Aug;18(4):820-8
12925008
Bone Marrow Transplant. 2003 Aug;32 Suppl 1:S23-4
12931235
Stroke. 2003 Sep;34(9):2258-63
12881607
J Neurosci. 2004 Jan 21;24(3):692-701
14736855
Brain Res Brain Res Rev. 2004 Mar;44(2-3):141-53
15003390
Int J Biochem Cell Biol. 2004 Apr;36(4):568-84
15010324
J Neurosci Res. 2004 Apr 1;76(1):121-8
15048936
J Clin Invest. 2004 Apr;113(7):1059-68
15057313
J Neurosci. 2004 May 12;24(19):4585-95
15140930
Brain Res. 2004 Oct 15;1023(2):213-21
15374747
Neurosci Lett. 2004 Nov 11;370(2-3):160-5
15488315
Prog Neurobiol. 1988;31(2):85-108
3041453
Ann Neurol. 1991 May;29(5):575
1859190
Exp Neurol. 1995 Jun;133(2):125-37
7649219
Prog Neurobiol. 1996 Dec;50(5-6):597-653
9015829
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14482-6
10588731
Exp Neurol. 2000 Feb;161(2):535-61
10686075
Drugs. 2000 Jul;60(1):23-33
10929928
J Neurosci Res. 2000 Aug 15;61(4):364-70
10931522
Nat Neurosci. 2000 Oct;3(10):986-91
11017170
Science. 2000 Dec 1;290(5497):1775-9
11099418
Science. 2000 Dec 1;290(5497):1779-82
11099419
J Neurosci. 2000 Dec 1;20(23):8788-801
11102487
Novartis Found Symp. 2000;231:7-15; discussion 16-20
11131546
Novartis Found Symp. 2000;231:110-23; discussion 123-8, 145-7
11131534
Genes Dev. 2001 Jan 15;15(2):188-200
11157775
Trends Pharmacol Sci. 2006 Dec;27(12):652-8
17056128
J Cereb Blood Flow Metab. 2007 Jan;27(1):1-5
16685255
J Biol Chem. 2007 Feb 16;282(7):4772-81
17158100
Epilepsia. 2007;48 Suppl 1:26-30
17316410
Neurodegener Dis. 2007;4(1):28-33
17429216
J Cereb Blood Flow Metab. 2007 May;27(5):919-27
17119544
Brain. 2007 May;130(Pt 5):1276-88
17472985
Neurosci Lett. 2003 Jun 5;343(2):129-33
12759181
Epilepsia. 2003 Jul;44(7):877-85
12823569
N Engl J Med. 2001 Mar 8;344(10):710-9
11236774
Nature. 2001 May 24;411(6836):494-8
11373684
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7611-6
11404469
Blood Cells Mol Dis. 2001 May-Jun;27(3):632-6
11482877
Nat Cell Biol. 2001 Sep;3(9):778-84
11533656
Pharmacol Rev. 2001 Dec;53(4):527-52
11734617
Neurobiol Dis. 2001 Dec;8(6):942-52
11741390
Exp Neurol. 2002 Mar;174(1):11-20
11869029
Pharmacol Biochem Behav. 2002 Oct;73(3):573-81
12151032
J Neurosci Res. 2002 Sep 1;69(5):614-21
12210827
Cell Transplant. 2002;11(5):481-8
12382678
Neuron. 2002 Dec 5;36(5):855-68
12467589
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1364-9
12538864
Hum Gene Ther. 2002 Dec 10;13(18):2197-201
12542850
RNA. 2003 Apr;9(4):493-501
12649500
Nature. 2003 Apr 17;422(6933):688-94
12700753
Science. 1998 Mar 6;279(5356):1528-30
9488650
Science. 1999 Jan 22;283(5401):534-7
9915700
Science. 1999 May 14;284(5417):1168-70
10325227
Nature. 1999 Sep 23;401(6751):390-4
10517639
Nat Cell Biol. 2004 Nov;6(11):1082-93
15517002
Epilepsy Res. 2004 Jul-Aug;60(2-3):77-159
15540387
Neuroscientist. 2005 Feb;11(1):25-36
15632276
Cloning Stem Cells. 2004;6(4):369-74
15671665
Mol Ther. 2005 Mar;11(3):390-8
15727935
Exp Neurol. 2005 May;193(1):53-64
15817264
J Gene Med. 2005 Jun;7(6):718-28
15712343
NeuroRx. 2004 Oct;1(4):382-93
15717042
Epilepsia. 2005 Aug;46(8):1162-9
16060924